(VIANEWS) - Moderna (MRNA), ACM Research (ACMR), Coty (COTY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Moderna (MRNA)
1202.8% sales growth and 72.43% return on equity
Moderna's sales growth this year is expected to be 2434.2% and a negative 2.5% for next year.
Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.
Volume
Today's last reported volume for Moderna is 3731030 which is 56.65% below its average volume of 8607470.
Moderna's sales growth for the next quarter is 1202.8%. The company's growth estimates for the current quarter and the next is 1694.9% and 1681.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 72.43%.
Volatility
Moderna's last day, last week, and last month's current intraday variation average was 0.53%, 2.11%, and 5.30%, respectively.
Moderna's highest amplitude of average volatility was 5.52% (day), 5.34% (last week), and 9.63% (last month), respectively.
Moderna's Stock Yearly Top and Bottom Value
Moderna's stock is valued at $165.71 at 11:22 EST, way below its 52-week high of $497.49 and way higher than its 52-week low of $102.66.
Moderna's Moving Average
Moderna's worth is way under its 50-day moving average of $298.96 and way under its 200-day moving average of $267.83.Previous days news about Moderna(MRNA)
- Etsy, Moderna lead the S&P 500 higher. According to Benzinga on Tuesday, 22 March, "Tesla Inc (NASDAQ: TSLA), Moderna Inc (NASDAQ: MRNA) and Etsy Inc (NASDAQ: ETSY) were among the top gainers for the SPY Tuesday."
- According to Bloomberg Quint on Monday, 21 March, "Pfizer and Moderna executives say they're trying to plan for anything and everything. ", "Given how long it takes to make a vaccine, companies like Moderna can't "sit and wait" to see what variants might arise in the spring, or what recommendations the WHO panel comes up with in a few months. "
2. ACM Research (ACMR)
77.5% sales growth and 8.42% return on equity
ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide.
ACM Research's sales growth this year is anticipated to be 50.1% and 26.8% for next year.
Year-on-year quarterly revenue growth grew by 108.8%, now sitting on 259.75M for the twelve trailing months.
Volume
Today's last reported volume for ACM Research is 247979 which is 23.25% below its average volume of 323103.
ACM Research's sales growth for the next quarter is 77.5%. The company's growth estimates for the current quarter and the next is a negative 37.1% and 173.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.42%.
Volatility
ACM Research's last day, last week, and last month's current intraday variation average was 4.09%, 6.71%, and 6.50%, respectively.
ACM Research's highest amplitude of average volatility was 9.48% (day), 10.80% (last week), and 9.82% (last month), respectively.
ACM Research's Stock Yearly Top and Bottom Value
ACM Research's stock is valued at $61.80 at 11:22 EST, way below its 52-week high of $119.12 and way above its 52-week low of $42.22.
ACM Research's Moving Average
ACM Research's value is way below its 50-day moving average of $76.91 and way under its 200-day moving average of $89.31.3. Coty (COTY)
10.2% sales growth and 7.67% return on equity
Coty Inc., together with its subsidiaries, engages in the manufacture, marketing, distribution, and sale of beauty products worldwide.
Coty's sales growth this year is anticipated to be 14.4% and 6.1% for next year.
Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 5.04B for the twelve trailing months.
Volume
Today's last reported volume for Coty is 7542960 which is 18.95% below its average volume of 9307520.
Coty's sales growth is a negative 0% for the present quarter and 10.2% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 0% and 111.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.67%.
Volatility
Coty's last day, last week, and last month's current intraday variation average was 0.37%, 5.68%, and 3.01%, respectively.
Coty's highest amplitude of average volatility was 5.41% (day), 8.46% (last week), and 5.51% (last month), respectively.
Coty's Stock Yearly Top and Bottom Value
Coty's stock is valued at $8.10 at 11:22 EST, way below its 52-week high of $11.12 and way above its 52-week low of $7.24.
Coty's Moving Average
Coty's worth is way below its 50-day moving average of $9.08 and below its 200-day moving average of $8.96.4. Nasdaq Inc (NDAQ)
8.5% sales growth and 18.64% return on equity
Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide.
Nasdaq Inc's sales growth this year is anticipated to be 16.4% and 4.3% for next year.
Year-on-year quarterly revenue growth declined by 4%, now sitting on 5.88B for the twelve trailing months.
Volume
Today's last reported volume for Nasdaq Inc is 72864 which is 92.4% below its average volume of 959222.
Nasdaq Inc's sales growth for the next quarter is 8.5%. The company's growth estimates for the present quarter and the next is 11.1% and 9.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.64%.
Volatility
Nasdaq Inc's last day, last week, and last month's current intraday variation average was 0.28%, 0.90%, and 1.53%, respectively.
Nasdaq Inc's highest amplitude of average volatility was 1.12% (day), 1.45% (last week), and 1.98% (last month), respectively.
Nasdaq Inc's Stock Yearly Top and Bottom Value
Nasdaq Inc's stock is valued at $174.92 at 11:22 EST, way below its 52-week high of $214.96 and way higher than its 52-week low of $123.90.
Nasdaq Inc's Moving Average
Nasdaq Inc's worth is way under its 50-day moving average of $204.16 and under its 200-day moving average of $180.16.5. United Natural Foods (UNFI)
6% sales growth and 16.21% return on equity
United Natural Foods, Inc., together with its subsidiaries, distributes natural, organic, specialty, produce, and conventional grocery and non-food products in the United States and Canada.
United Natural Foods's sales growth this year is expected to be 6.4% and 2.7% for next year.
Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 27.78B for the twelve trailing months.
Volume
Today's last reported volume for United Natural Foods is 1129150 which is 88.05% above its average volume of 600426.
United Natural Foods's sales growth is a negative 0% for the present quarter and 6% for the next. The company's growth estimates for the present quarter and the next is 4.3% and negative -7.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.21%.
Volatility
United Natural Foods's last day, last week, and last month's current intraday variation average was 0.36%, 3.11%, and 2.90%, respectively.
United Natural Foods's highest amplitude of average volatility was 3.38% (day), 5.31% (last week), and 5.47% (last month), respectively.
United Natural Foods's Stock Yearly Top and Bottom Value
United Natural Foods's stock is valued at $41.55 at 11:22 EST, way below its 52-week high of $57.89 and way above its 52-week low of $30.61.